Papers
1
Total Citations
2
H-Index
1
About
Shiwen Mai is a pioneering researcher in regenerative medicine and cellular reprogramming, with a primary focus on advancing the production of high-quality induced pluripotent stem cells (iPSCs) for clinical applications. Their most notable contribution is the development of a robotic-based spatial-restricting structured flow system for selecting monoclonal cell lineages from somatic reprogramming, a breakthrough that addresses the critical challenge of lineage heterogeneity in iPSC generation. This innovative approach, detailed in their 2024 paper, enhances the purity and consistency of reprogrammed cell lines, which is essential for personalized disease modeling and therapeutic use. While their work is still emerging, with their key paper accumulating 2 citations, Mai’s research holds significant promise for streamlining stem cell manufacturing and reducing variability in regenerative treatments. By integrating automation and spatial control into cell selection, Mai is helping to bridge the gap between laboratory reprogramming and scalable, reproducible clinical-grade cell production, positioning them as an emerging leader in the field of stem cell biotechnology.
Research Focus
Key Achievements
Top Papers
- 1